UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2002, Dai 1-han., ISBN 9784872336955, 605
Book
Cancer science, ISSN 1347-9032, 03/2019, Volume 110, Issue 3, pp. 1012 - 1020
pembrolizumab | phase 1 | non–small‐cell lung cancer | immunotherapy | PD‐L1 | PD-L1 | non–small-cell lung cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Lung Neoplasms - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Male | Antineoplastic Agents - therapeutic use | Disease-Free Survival | Asian Continental Ancestry Group | B7-H1 Antigen - metabolism | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Medical research | Care and treatment | Chemotherapy | Immunotherapy | Monoclonal antibodies | Medicine, Experimental | Lung cancer, Non-small cell | Cancer | Medical imaging | Cell survival | Toxicity | Mortality | Lung cancer | Non-small cell lung carcinoma | Cytotoxicity | Metastasis | Cancer therapies | Pembrolizumab | Pneumonitis | Platinum | Antitumor activity | Ligands | Death | Mutation | Apoptosis | Pharmaceuticals | Index Medicus | Original
Journal Article
The Lancet (British edition), ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Lung cancer | Oncology | Kinases | Cancer therapies | Evidence-based medicine | Metastases | Pembrolizumab | Randomization | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Health care facilities | Hypothyroidism | Survival | Patients | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 02/2020, Volume 201, Issue 4, pp. E12 - E12
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Pneumonia - physiopathology | Occupational Exposure - adverse effects | Pneumonia - chemically induced | Humans | Pneumonia - diagnosis | Inhalation Exposure - adverse effects | Phosphorus - adverse effects | Adult | Male | Lung - diagnostic imaging | Lung - physiopathology | Tomography | Phosphorus | Respiratory diseases | Lung diseases | Index Medicus | Abridged Index Medicus
Journal Article
American journal of obstetrics and gynecology, ISSN 0002-9378, 07/2019, Volume 221, Issue 1, pp. 71 - 72
Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Uterine Neoplasms - therapy | Adenocarcinoma - pathology | Uterine Neoplasms - pathology | Humans | Pleural Effusion - diagnostic imaging | Tomography, X-Ray Computed | Adult | Female | Pleural Effusion - etiology | Uterine Neoplasms - diagnosis | Neoplasms, Cystic, Mucinous, and Serous - complications | Paclitaxel - administration & dosage | Omentum - surgery | Ascites - etiology | Neoplasms, Cystic, Mucinous, and Serous - pathology | Ascites - diagnostic imaging | Carboplatin - administration & dosage | Hysterectomy | Adenocarcinoma - complications | Adenocarcinoma - diagnosis | Salpingo-oophorectomy | Neoplasms, Cystic, Mucinous, and Serous - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Meigs Syndrome - diagnosis | Uterine Neoplasms - complications | Radiography, Thoracic | Neoplasms, Cystic, Mucinous, and Serous - diagnosis | Index Medicus | Abridged Index Medicus
Journal Article
Cancer science, ISSN 1347-9032, 09/2019, Volume 110, Issue 9, pp. 2884 - 2893
EGFR mutation | non‐small‐cell lung cancer | tyrosine kinase inhibitor | acquired resistance | osimertinib | Life Sciences & Biomedicine | Oncology | Science & Technology | Japan - epidemiology | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | ErbB Receptors - genetics | Diarrhea - epidemiology | Lung Neoplasms - pathology | Lung Diseases, Interstitial - chemically induced | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Diarrhea - chemically induced | Paronychia - epidemiology | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Aged, 80 and over | Adult | Aniline Compounds - administration & dosage | Lung Diseases, Interstitial - epidemiology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Paronychia - chemically induced | ErbB Receptors - antagonists & inhibitors | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Survival Rate | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Exanthema - epidemiology | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Acrylamides - administration & dosage | Progression-Free Survival | Survival Analysis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Aniline Compounds - adverse effects | Acrylamides - adverse effects | Drug Resistance, Neoplasm - drug effects | Tyrosine | Medical research | Chemotherapy | Analysis | Medicine, Experimental | Development and progression | Respiratory tract diseases | Lung cancer, Non-small cell | Cancer | Epidermal growth factor receptors | Research funding | Lung cancer | Lung diseases | Clinical trials | Diarrhea | Non-small cell lung carcinoma | Cancer therapies | Studies | Epidermal growth factor | Platinum | Skin | Mutation | Safety | Protein-tyrosine kinase | Pharmaceuticals | Index Medicus | Original
Journal Article
Clinical rheumatology, ISSN 0770-3198, 04/2020, Volume 39, Issue 6, pp. 2017 - 2018
Journal Article
10.
Full Text
Endobronchial lesions of mycobacterium abscessus infection in an immunocompromised patient
American journal of respiratory and critical care medicine, ISSN 1073-449X, 05/2017, Volume 195, Issue 9, pp. e37 - e38
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Bronchoscopy | Humans | Dasatinib - therapeutic use | Mycobacterium Infections, Nontuberculous - etiology | Administration, Inhalation | Male | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy | Tuberculosis, Pulmonary - pathology | Tacrolimus - adverse effects | Mycobacterium Infections, Nontuberculous - pathology | Adrenal Cortex Hormones - adverse effects | Tuberculosis, Pulmonary - immunology | Protein Kinase Inhibitors - therapeutic use | Adult | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Tuberculosis, Pulmonary - etiology | Immunocompromised Host | Mycobacterium Infections, Nontuberculous - immunology | Bronchi - pathology | Peripheral Blood Stem Cell Transplantation | Tomography | Infections | Patients | Milk | Index Medicus | Abridged Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 257 - 257
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Earth magnetosphere | Visualization | Satellites | Resonant interactions | Particle interactions | Electromagnetic waves | Electron precipitation | Waveforms | Electromagnetic radiation | Universe | Plasmas | Electrons
Journal Article
Clinical cancer research, ISSN 1078-0432, 07/2006, Volume 12, Issue 13, pp. 3915 - 3921
NSCLC | Gefitinib | EGFR and serum DNA | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Predictive Value of Tests | Receptor, Epidermal Growth Factor - genetics | Sequence Deletion | Follow-Up Studies | Humans | Middle Aged | Male | DNA Mutational Analysis - methods | DNA, Neoplasm - blood | Reverse Transcriptase Polymerase Chain Reaction - methods | Sensitivity and Specificity | Aged, 80 and over | Adult | Female | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Genotype | Survival Rate | Treatment Outcome | Disease Progression | Disease-Free Survival | Point Mutation | Quinazolines - therapeutic use | Carcinoma, Non-Small-Cell Lung - blood | Aged | Lung Neoplasms - blood | Carcinoma, Non-Small-Cell Lung - drug therapy | DNA, Neoplasm - genetics | Neoplasm Staging | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 2467 - 2467
Journal Article
Cancer science, ISSN 1347-9032, 04/2018, Volume 109, Issue 4, pp. 1177 - 1184
cytology | T790M | epidermal growth factor receptor | non‐small cell lung cancer | osimertinib | non-small cell lung cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Acrylamides | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - genetics | Aniline Compounds | Humans | Middle Aged | ErbB Receptors - genetics | Male | Mutation - genetics | Piperazines - pharmacology | Disease-Free Survival | Asian Continental Ancestry Group | Mutation - drug effects | Aged, 80 and over | Adult | Female | Aged | Antineoplastic Agents - pharmacology | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Tyrosine | Medical research | Care and treatment | Development and progression | Lung cancer, Small cell | Lung cancer, Non-small cell | Complications and side effects | Epidermal growth factor | Analysis | Medicine, Experimental | Skin | Diagnosis | Cancer | Plasma | Peptides | Epidermal growth factor receptors | Research funding | Lung cancer | Cytology | Stockholders | Diarrhea | Non-small cell lung carcinoma | Cancer therapies | Patients | Disease control | Studies | Acids | Cellular biology | Biopsy | Mutation | Protein-tyrosine kinase | Tumors | Index Medicus | Original
Journal Article